FutureChem signs $1.26M radiopharmaceutical supply contract with Avid

FutureChem has signed a contract with Eli Lilly subsidiary Avid to manufacture and supply radiopharmaceuticals for Alzheimer's diagnostic clinical trials in South Korea, valued at $1.259 million.

“계약 규모는 125만9000달러(약 15억4000만원)로, 국내 임상시험에 필요한 알츠하이머 진단용 방사성 의약품 위탁생산 및 공급계약이다.”asiae.co.kr

• 1 source
• asiae.co.kr퓨쳐켐, 125만달러 규모 임상시험용 방사성 의약품 위탁생산·공급계약이관주 기자Apr 18, 2022

Summarized from public sources; check the original articles before acting on it.